An HPLC-MS/MS method for simultaneous determination of decitabine and its valyl prodrug valdecitabine in rat plasma.

[1]  M. Qiao,et al.  Development and validation of a liquid chromatography-tandem mass spectrometry method for quantification of decitabine in rat plasma. , 2012, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[2]  K. Döhner,et al.  A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy , 2012, Haematologica.

[3]  S. Guichard,et al.  Simultaneous determination of decitabine and vorinostat (Suberoylanalide hydroxamic acid, SAHA) by liquid chromatography tandem mass spectrometry for clinical studies. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[4]  J. Dipersio,et al.  Pharmacokinetics of decitabine administered as a 3-h infusion to patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) , 2008, Cancer Chemotherapy and Pharmacology.

[5]  J. Issa,et al.  Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia. , 2007, Blood.

[6]  M. Grever,et al.  Characterization of decomposition products and preclinical and low dose clinical pharmacokinetics of decitabine (5-aza-2'-deoxycytidine) by a new liquid chromatography/tandem mass spectrometry quantification method. , 2006, Rapid communications in mass spectrometry : RCM.

[7]  John M Bennett,et al.  Decitabine improves patient outcomes in myelodysplastic syndromes , 2006, Cancer.

[8]  S. Sacchi,et al.  Chronic myelogenous leukemia in nonlymphoid blastic phase , 1999, Cancer.

[9]  G. Rivard,et al.  Sample preparation for the determination of 5-aza-2'-deoxycytidine in plasma by high-performance liquid chromatography. , 1985, Journal of chromatography.

[10]  G. Rivard,et al.  Sample preparation and estimation of plasma concentration of 3-deazauridine by high-performance liquid chromatography. , 1983, Therapeutic Drug Monitoring.